Visit COVID-19 resources

[Skip to Content]

Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose? – (Eye Journal)

26 November 2019

This news item is available to RCOphth members only, please log in below to access.

Members Login